References
- Babapulle MN, Joseph L, Bélisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drugeluting stents. Lancet 2004;364:583-91. https://doi.org/10.1016/S0140-6736(04)16850-5
- Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. https://doi.org/10.1056/NEJMoa035071
- Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31. https://doi.org/10.1056/NEJMoa032441
- Beohar N, Meyers SN, Erdogan A, et al. Off-label use of drug-eluting versus bare metal stents: a lesion-specific systematic review of longterm outcomes. J Interv Cardiol 2010;23:528-45. https://doi.org/10.1111/j.1540-8183.2010.00588.x
- Serruys PW, Onuma Y, Garg S, et al. 5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimuseluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010;55:1093-101. https://doi.org/10.1016/j.jacc.2009.11.049
- Ellis SG, Stone GW, Cox DA, et al. Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent). JACC Cardiovasc Interv 2009;2:1248-59. https://doi.org/10.1016/j.jcin.2009.10.003
- Caixeta A, Leon MB, Lansky AJ, et al. 5-year clinical outcomes after sirolimus- eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009;54:894-902. https://doi.org/10.1016/j.jacc.2009.04.077
- Win HK, Caldera AE, Maresh K, et al. Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents. JAMA 2007; 297:2001-9. https://doi.org/10.1001/jama.297.18.2001
- Planer D, Beyar R, Almagor Y, et al. Long-term (>3 Years) outcome and predictors of clinical events after insertion of sirolimus-eluting stent in one or more native coronary arteries (from the Israeli arm of the e-Cypher registry). Am J Cardiol 2008;101:953-9. https://doi.org/10.1016/j.amjcard.2007.11.043
- Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010;56:1897-907. https://doi.org/10.1016/j.jacc.2010.07.028
- Lee CW, Park SJ. Predictive factors for restenosis after drug-eluting stent implantation. Korean Circ J 2007;37:97-102. https://doi.org/10.4070/kcj.2007.37.3.97
- Park K, Park KW, Rha SW, et al. Comparison of 5-year clinical outcomes between sirolimus-versus paclitaxel-eluting stent: Korean multicenter network analysis of 9000-patient cohort. Circ Cardiovasc Interv 2012; 5:174-84. https://doi.org/10.1161/CIRCINTERVENTIONS.111.964650
- Park KW, Kim CH, Lee HY, et al. Does "late catch-up" exist in drug-eluting stents: insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents. Am Heart J 2010;159:446-53. https://doi.org/10.1016/j.ahj.2010.01.001
- Ko YG, Kim JS, Choi D, et al. Five-year outcomes of sirolimus-eluting versus paclitaxel-eluting stents: a propensity matched study: clinical evidence of late catch-up? Int J Cardiol 2011;152:302-6. https://doi.org/10.1016/j.ijcard.2010.07.023
- Brodie BR, Stuckey T, Downey W, et al. Outcomes and complications with off-label use of drug-eluting stents: results from the STENT (Strategic Transcatheter Evaluation of New Therapies) group. JACC Cardiovasc Interv 2008;1:405-14. https://doi.org/10.1016/j.jcin.2008.06.005
- Weisz G, Leon MB, Holmes DR Jr, et al. Five-year follow-up after sirolimus- eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. J Am Coll Cardiol 2009;53:1488-97. https://doi.org/10.1016/j.jacc.2009.01.050
- Kandzari DE, Mauri L, Popma JJ, et al. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). JACC Cardiovasc Interv 2011;4:543-50. https://doi.org/10.1016/j.jcin.2010.12.014
- Nikol S, Huehns TY, Hofling B. Molecular biology and post-angioplasty restenosis. Atherosclerosis 1996;123:17-31. https://doi.org/10.1016/0021-9150(96)05807-8
- Serruys PW, Daemen J, Morice MC, et al. Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease. EuroIntervention 2008;3:450-9. https://doi.org/10.4244/EIJV3I4A81
- Suh J, Park DW, Lee JY, et al. The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation. JACC Cardiovasc Interv 2010;3:383-9. https://doi.org/10.1016/j.jcin.2009.10.033
- Kim YH, Park SW, Lee SW, et al. Sirolimus-eluting stent versus paclitaxel- eluting stent for patients with long coronary artery disease. Circulation 2006;114:2148-53. https://doi.org/10.1161/CIRCULATIONAHA.106.666396
- Dawkins KD, Grube E, Guagliumi G, et al. Clinical efficacy of polymerbased paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 2005;112:3306-13. https://doi.org/10.1161/CIRCULATIONAHA.105.552190
- Colombo A, De Gregorio J, Moussa I, et al. Intravascular ultrasoundguided percutaneous transluminal coronary angioplasty with provisional spot stenting for treatment of long coronary lesions. J Am Coll Cardiol 2001;38:1427-33. https://doi.org/10.1016/S0735-1097(01)01557-1
- Katritsis DG, Korovesis S, Tzanalaridou E, Giazitzoglou E, Voridis E, Meier B. Comparison of long versus short ("spot") drug-eluting stenting for long coronary stenoses. Am J Cardiol 2009;104:786-90. https://doi.org/10.1016/j.amjcard.2009.04.056
- Katritsis DG, Korovesis S, Tzanalaridou E, Giazitzoglou E, Zografos T, Meier B. Spot drug-eluting stenting for long coronary stenoses: longterm results of a randomized clinical study. J Interv Cardiol 2011;24:437-41. https://doi.org/10.1111/j.1540-8183.2011.00662.x